Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review
ASIDE Case Reports · 2026
DOI: 10.71079/aside.cr.021426352 ↗Kurz gefasst
Fallbericht in der Zeitschrift ASIDE Case Reports, 2026. Verfasst von Lorenzo Salvati und 3 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
COVID-19 vaccines have demonstrated a favorable safety profile in diverse populations, including patients with autoimmune rheumatic diseases. However, rare adverse events such as disease flares and vaccine-triggered autoimmune manifestations have been reported. This study presents a case of subacute cutaneous lupus erythematosus (SCLE) following BNT162b2 vaccination and a narrative review of the literature.
Methods
We describe the case of an 80-year-old woman with noninfectious aortitis who developed SCLE, annular-polycyclic type, following BNT162b2 vaccination and review published cases of SCLE after anti-SARS-CoV-2 vaccination.
Results
A review of 18 published cases and 19 total, including the current case of SCLE following anti-SARS-CoV-2 vaccination, suggests that most reported patients were adult women, with and without underlying autoimmune rheumatic diseases. SCLE typically develops within days of the first vaccine dose, with most cases following mRNA-based vaccination.
Conclusions
Although based on a limited number of case reports and subject to reporting bias, these findings underscore the potential for anti-SARS-CoV-2 vaccines to trigger autoimmune cutaneous reactions not exclusively in predisposed individuals, emphasizing the need for vigilance while reinforcing the overall safety and benefit of vaccination in patients with autoimmune rheumatic diseases. The incidence of SCLE following COVID-19 vaccination, and the causal relationship between vaccination and SCLE, cannot be inferred from case reports or pharmacovigilance data alone.
Zitieren
APA
Salvati, L., Carria, M. D., Parronchi, P., & Cammelli, D. (2026). Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review. ASIDE Case Reports. https://doi.org/10.71079/aside.cr.021426352
Vancouver
Salvati L, Carria MD, Parronchi P, Cammelli D. Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review. ASIDE Case Reports. 2026. doi:10.71079/aside.cr.021426352
BibTeX
@article{Salvati2026,
author = {Salvati, Lorenzo and Carria, Marco Del and Parronchi, Paola and Cammelli, Daniele},
title = {Subacute Cutaneous Lupus Erythematosus Following COVID-19 Vaccination: A Case Report after BNT162b2 Vaccine and Literature Review},
journal = {ASIDE Case Reports},
year = {2026},
doi = {10.71079/aside.cr.021426352}
}
EUVIMED